Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP352411.RAfIWtSJ0nYjZynoabvHqxf87kE-slMC7bIx9cXDX52_E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP352411.RAfIWtSJ0nYjZynoabvHqxf87kE-slMC7bIx9cXDX52_E130_assertion type Assertion NP352411.RAfIWtSJ0nYjZynoabvHqxf87kE-slMC7bIx9cXDX52_E130_head.
- NP352411.RAfIWtSJ0nYjZynoabvHqxf87kE-slMC7bIx9cXDX52_E130_assertion description "[The present study was designed to investigate the efficacy of combination gene therapy using adenoviral vectors expressing gene products shown to possess apoptotic activity: E2F-1 (Ad-E2F-1) and a C-terminal deletion mutant of p21(WAF1/cIP1) (Ad-p21(-PCNA)), on growth inhibition and apoptosis of human colon cancer cells in vitro and in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352411.RAfIWtSJ0nYjZynoabvHqxf87kE-slMC7bIx9cXDX52_E130_provenance.
- NP352411.RAfIWtSJ0nYjZynoabvHqxf87kE-slMC7bIx9cXDX52_E130_assertion evidence source_evidence_literature NP352411.RAfIWtSJ0nYjZynoabvHqxf87kE-slMC7bIx9cXDX52_E130_provenance.
- NP352411.RAfIWtSJ0nYjZynoabvHqxf87kE-slMC7bIx9cXDX52_E130_assertion SIO_000772 11961668 NP352411.RAfIWtSJ0nYjZynoabvHqxf87kE-slMC7bIx9cXDX52_E130_provenance.
- NP352411.RAfIWtSJ0nYjZynoabvHqxf87kE-slMC7bIx9cXDX52_E130_assertion wasDerivedFrom befree-2016 NP352411.RAfIWtSJ0nYjZynoabvHqxf87kE-slMC7bIx9cXDX52_E130_provenance.
- NP352411.RAfIWtSJ0nYjZynoabvHqxf87kE-slMC7bIx9cXDX52_E130_assertion wasGeneratedBy ECO_0000203 NP352411.RAfIWtSJ0nYjZynoabvHqxf87kE-slMC7bIx9cXDX52_E130_provenance.